Cells with high aldehyde dehydrogenase (ALDH) activity have been shown to represent a population of cancer stem cells (CSCs) in differentiated thyroid carcinomas (DTCs), which can be used to apply DSF (ALDH inhibitor). This evidence concerns the gene LDHA and thyroid gland carcinoma.